Background Despite robust evidence concerning self-management for some long-term
conditions (LTCs), others lack research explicitly on self-management and, consequently …

Background Depression is common and clinical trials are crucial for evaluating treatments.
Difficulties in recruiting participants into depression trials are well-documented, yet no study …

Background Despite the importance of timely management of patients with inflammatory
arthritis (IA), delays exist in its diagnosis and treatment. Objective To perform a systematic …

With musculoskeletal conditions now identified as the second highest cause of the morbidity-
related global burden of disease, models of care for the prevention and management of …

Background Online symptom checkers are increasingly used by patients however there is
little published evidence of their effectiveness in real patients. The aim of this study was to …

Objective. The aim of this study was to explore symptoms and symptom development during
the earliest phases of RA in patients with seropositive arthralgia and patients newly …

Objective To investigate delays from symptom onset to rheumatology assessment for
patients with a new onset of rheumatoid arthritis (RA) or unclassified arthritis. Methods …

In low-and-middle-income countries, people develop chronic diseases at a younger age,
leading to health-and-economic loss. Estimates of the age of onset of chronic disease …

Background: The Wait Time Alliance recently established wait time benchmarks for
rheumatology consultations in Canada. Our aim was to quantify wait times to primary and …

Background Rheumatoid arthritis is an autoimmune disease that causes joint inflammation.
It affects around 400,000 people in the UK and 1 million adults in the USA. Given the …